GCCL (Global Clinical Central Lab), a company specializes in clinical trial sample analysis, announced on Mar. 17 that it has built a resource management system for Peripheral Blood Mononuclear Cells (PBMCs), or PBMC Resource Management System. Under the PBMC Resource Management System, the whole process of PBMC testing, from the arrival of an original sample, centrifugation, and production of vials for split sample PBMC, to storage, dispatch mapping and disposal, is managed and stored in a computerized system using 2 barcodes. The system creates exclusive barcodes for each original and split samples after mapping, and the end-to-end testing cycle is computerized in the system. This will prevent human errors from manual entry and allow real-time data provision upon customer request. “With more and more clinical trials for new biologic drug development, such as immunotherapy drugs require Cell Mediated Immunogenicity (CMI) analysis, we have decided to build this IT system to ensure excellent PBMC production and management services for customers.”, said Hee-Joo Lee, Vice President of GCCL Lab Operation. She added, “This system development is expected to bring safer, more efficient and credible sample management services.”
